Work

High Response Rate of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia Includes Eradication of Minimal Residual Disease: Potential Importance for Outcome

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.4161.4161

Authors: Robert J. Kreitman, Evgeny Arons, Martin S Tallman, Robak Tadeusz, Steven Coutre, Wyndham H Wilson, Maryalice Stetler-Stevenson, Constance M. Yuan, Mark Lanasa, David JP FitzGerald, Ira Pastan

Institutions: National Institutes of Health, National Cancer Institute, Memorial Sloan Kettering Cancer Center, Medical University of Lodz, Stanford Medicine, Stanford University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2525329205

FWCI: 0.491

Cites:

Cited by: 4

Related to: 10